Welcome to
On Feet Nation
Rick Taylor Online
Jonathan Online
Leslie Online
Thomas Online
Steven Online
Garcia Jones Online
Posted by Ab12 on April 29, 2024 at 5:15am 0 Comments 0 Likes
Posted by Deccce dsa on April 29, 2024 at 5:13am 0 Comments 0 Likes
Roots Analysis has announced the addition of “CAR-T Cell Therapy Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and…
ContinueAdded by Alex Wilson on June 20, 2022 at 3:07am — No Comments
Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.
Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Experts believe that a strong biosimilar portfolio is equivalent to a blockbuster product, at least for companies with marketing power and…
ContinueAdded by Alex Wilson on June 15, 2022 at 2:36am — No Comments
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.
The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced…
ContinueAdded by Alex Wilson on June 9, 2022 at 2:31am — No Comments
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.
The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced…
ContinueAdded by Alex Wilson on June 2, 2022 at 5:51am — No Comments
Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings.
According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed…
ContinueAdded by Alex Wilson on May 30, 2022 at 3:05am — No Comments
Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.
Detailed review of the adalimumab biosimilars pipeline and affiliated developer landscape, featuring a list of involved innovator companies and their respective therapy candidates. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of…
ContinueAdded by Alex Wilson on May 26, 2022 at 6:24am — No Comments
Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings.
Success of approved squamous non-small cell lung cancer therapies, such as Keytruda®, Opdivo® and Portrazza®, has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of these therapies to effectively treat NSCLC, an aggressive form of squamous cell carcinoma, lung carcinoma, justifies…
ContinueAdded by Alex Wilson on May 23, 2022 at 7:02am — No Comments
Roots Analysis has announced the addition of “Soft Tissue Sarcoma: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma Market, 2021-2030” report to its list of offerings.
Soft tissue sarcoma is a rare form of cancer that usually originates in soft / connective tissues and most commonly affects the abdomen, arms, head, legs, neck and trunk of the individual. It is worth noting that, till date, many types (50+) of soft tissue sarcoma have been identified. However, since these tumors…
ContinueAdded by Alex Wilson on May 9, 2022 at 7:29am — No Comments
In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines. In fact, 60-70% of manufacturing processes of available biologics require live mammalian systems. A cell line refers to a…
ContinueAdded by Alex Wilson on May 2, 2022 at 2:24am — No Comments
Roots Analysis has announced the addition of “Pharmaceutical Secondary Packaging Market” report to its list of offerings.
The anticipated growth in the therapeutics pipeline is likely to translate into a significant rise in the demand for cost-effective and quality secondary packaging solutions, presenting lucrative opportunities for contract packaging organizations. Driven by the growth of the overall pharmaceutical industry and increasing preference of drug developers for…
ContinueAdded by Alex Wilson on April 25, 2022 at 2:16am — No Comments
Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.”
The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:
A…
Added by Alex Wilson on April 21, 2022 at 3:14am — No Comments
Roots Analysis has announced the addition of “Biopreservation Media Providers Market” report to its list of offerings.
Several companies across the globe are now offering a variety of biopreservation media that assist the transport and storage of cells, tissues and organs, across various preservation conditions. It is worth highlighting that such pre-formulated media ensure product quality, efficacy, viability and post preservation high cell recovery. Given the inclination of industry…
ContinueAdded by Alex Wilson on April 11, 2022 at 7:42am — No Comments
The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to…
ContinueAdded by Alex Wilson on April 6, 2022 at 6:47am — No Comments
Added by Alex Wilson on April 6, 2022 at 6:47am — No Comments
The Novel Ocular Drug Delivery Devices Market report features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain.
According to the World Health Organization (WHO), more than 2.2 billion individuals across the world suffer from some degree of vision impairment caused due to various ophthalmic disorders,…
ContinueAdded by Alex Wilson on April 5, 2022 at 5:28am — No Comments
Amongst the total players having capability to offer services of inhaled and intranasal drug products, most of the players engaged in this domain are mid-sized firms. Of these, most of companies have been established before 2001. This is followed by the large firms of which, recently established large firms are (in alphabetical order) Kindeva Drug Delivery (2020) and Mapaex (2016).
A detailed information visit this…
ContinueAdded by Alex Wilson on April 4, 2022 at 2:54am — No Comments
Roots Analysis has announced the addition of “Gene-Editing Beyond CRISPR: Focus on ZFN, TALENs and Meganucleases Market, 2021-2035” report to its list of offerings.
The ability of gene editing solutions to directly target and modify genomic sequences has greatly expedited the progress of Gene editing therapies into clinical stages. The clinical trials data of ZFNs, TALENs and meganucleases based therapies demonstrate their potential in the treatment of various diseases, including…
ContinueAdded by Alex Wilson on March 31, 2022 at 5:37am — No Comments
Roots Analysis has announced the addition of “Regulatory T-Cell (Tregs) Therapies Market, 2021 – 2035” report to its list of offerings.
Given the various benefits offered, including high target specificity, customization potential and ability to generate immunological memory, regulatory T-cell (Treg) therapies have garnered significant attention among key industry stakeholders for the treatment of various oncological and non-oncological disease indications.
To order this 145+…
ContinueAdded by Alex Wilson on March 25, 2022 at 3:01am — No Comments
Roots Analysis has announced the addition of “Gene-Editing Beyond CRISPR: Focus on ZFN, TALENs and Meganucleases Market, 2021-2035” report to its list of offerings.
The ability of gene editing solutions to directly target and modify genomic sequences has greatly expedited the progress of gene editing therapies into clinical stages. The clinical trials data of ZFNs, TALENs and meganucleases based therapies demonstrate their potential in the treatment of various diseases, including…
ContinueAdded by Alex Wilson on March 24, 2022 at 1:50am — No Comments
As of today, most of the top revenue generating drugs, across the globe, are biologics. During our research, we were able to identify 67 top selling biologics (revenues equal to or above USD 500 million in 2020). Top selling biologics market has so far been primarily led by industry players. Majority of industry players have taken a step towards investing their time and resources for the development of biologic therapies. Genentech, Amgen, Janssen Biotech, Sanofi and Novo Nordisk are amongst…
ContinueAdded by Alex Wilson on March 23, 2022 at 1:35am — No Comments
© 2024 Created by PH the vintage. Powered by